Diana Hausman - Net Worth and Insider Trading

Diana Hausman Net Worth

The estimated net worth of Diana Hausman is at least $2 Million dollars as of 2024-11-13. Diana Hausman is the Chief Medical Officer of Zentalis Pharmaceuticals Inc and owns about 373,876 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $1 Million. Diana Hausman is also the Chief Medical Officer of Zymeworks Inc and owns about 7,377 shares of Zymeworks Inc (ZYME) stock worth over $128,360. Details can be seen in Diana Hausman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Diana Hausman has not made any transactions after 2024-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Diana Hausman

To

Diana Hausman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Diana Hausman owns 4 companies in total, including Zymeworks Inc (ZYME) , Cascadian Therapeutics Inc (CASC) , and Immuneering Corp (IMRX) among others .

Click here to see the complete history of Diana Hausman’s form 4 insider trades.

Insider Ownership Summary of Diana Hausman

Ticker Comapny Transaction Date Type of Owner
ZYME Zymeworks Inc 2021-03-10 Chief Medical Officer
CASC Cascadian Therapeutics Inc 2015-09-24 Chief Medical Officer
IMRX Immuneering Corp 2022-01-14 director
LIMIT LIMIT 2024-05-09 director

Diana Hausman Latest Holdings Summary

Diana Hausman currently owns a total of 2 stocks. Among these stocks, Diana Hausman owns 373,876 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of May 9, 2024, with a value of $1 Million and a weighting of 91.55%. Diana Hausman also owns 7,377 shares of Zymeworks Inc (ZYME) as of March 10, 2021, with a value of $128,360 and a weighting of 8.45%.

Latest Holdings of Diana Hausman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZNTL Zentalis Pharmaceuticals Inc 2024-05-09 373,876 3.72 1,390,819
ZYME Zymeworks Inc 2021-03-10 7,377 17.40 128,360

Holding Weightings of Diana Hausman


Diana Hausman Form 4 Trading Tracker

According to the SEC Form 4 filings, Diana Hausman has made a total of 1 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the sale of 3,356 shares on May 9, 2024, which brought Diana Hausman around $42,353.

According to the SEC Form 4 filings, Diana Hausman has made a total of 4 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Zymeworks Inc is the sale of 1,048 shares on March 10, 2021, which brought Diana Hausman around $36,628.

Insider Trading History of Diana Hausman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Diana Hausman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Diana Hausman Ownership Network

Ownership Network List of Diana Hausman

No Data

Ownership Network Relation of Diana Hausman

Insider Network Chart

Diana Hausman Owned Company Details

What does Zymeworks Inc do?

Who are the key executives at Zymeworks Inc?

Diana Hausman is the Chief Medical Officer of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .

Zymeworks Inc (ZYME) Insider Trades Summary

Over the past 18 months, Diana Hausman made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net purchase of 3,350,000 shares made by Ecor1 Capital, Llc , and a net sale of 23,904 shares made by Kenneth Galbraith .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 3,350,000 shares were bought by its insiders, resulting in a net purchase of 3,309,417 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zymeworks Inc Insider Transactions

No Available Data

Diana Hausman Mailing Address

Above is the net worth, insider trading, and ownership report for Diana Hausman. You might contact Diana Hausman via mailing address: C/o Oncothyreon Inc., 2601 Fourth Ave, Suite 500, Seattle Wa 98121.